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The Vision Loss Expert Group of the Global Burden of Dis-
ease study reported that globally there were 36 million blind 
people in 2015, of whom 11.7 million (32.5%) lived in South 
Asia.1 In addition, they found that 81.2% of all blindness 
was avoidable,2 though less than 50% may be avoidable in 
children.3 Internationally, blindness due to avoidable retinal 
disease is increasing.4 In particular, India is experiencing a 
so-called third epidemic of blindness caused by retinopathy 
of prematurity,5 in addition to a dramatic increase in diabetic 
retinopathy.6–8 The causes are, respectively, increased survival 
of preterm infants due to expanded provision of neonatal care 
and increased diabetes linked to an ageing population and 
lifestyle changes.9–12
In 2010, an estimated 32 200 infants globally had visual 
loss from retinopathy of prematurity.13 In India, the figure 
that year was 5000 (i.e. 15% of the global estimate) among 
the 3.52 million preterm births in the country (i.e. 23.6% of 
15 million preterm births globally).9,14,15 Between 10 and 47% 
of premature babies born under 32 weeks’ gestation who 
survive neonatal care develop retinopathy of prematurity16,17 
and up to 15% of survivors require treatment for sight-
threatening retinopathy.5,9 Risk factors for the condition are 
earlier prematurity, inadequate monitoring of supplemental 
oxygen, respiratory distress syndrome, anaemia and sepsis.13,18 
The risk of blindness can be reduced by minimizing preterm 
births, better neonatal care from birth and timely screening 
of infants at risk, with urgent treatment for those who develop 
sight-threatening retinopathy of prematurity.19 Screening and 
treatment of the condition have been reported to be highly 
cost–effective.20,21
Globally, 35.4% of people with diabetes mellitus were 
estimated to have diabetic retinopathy in 2012 and 11.7% 
had sight-threatening disease.22 In 2017, 73 of the 451 million 
people with diabetes worldwide (16.2%) lived in India.23 Stud-
ies carried out in the country over the last decade reported 
that diabetic retinopathy prevalence were approximately 
9.6% in rural areas24 and 18.0% (255/1414) in urban areas;7 
the rates of sight-threatening retinopathy in the two areas 
were 3.8% (45/1190) and 6.6% (39/592), respectively.8,25 Risk 
factors for diabetic retinopathy include longer duration of 
diabetes, poor diabetes control and hypertension. Evidence 
from high-income countries indicates that the risk of visual 
loss from diabetic retinopathy can be reduced by strategies 
such as better control of blood glucose and hypertension and 
regular screening to detect individuals with sight-threatening 
diabetic retinopathy, followed by confirmatory diagnosis and 
appropriate management.26
Current situation in India
India has a federal structure of governance with an elected 
national government and 28 state governments. Although 
the national government oversees the formulation of policies, 
medical education and health programmes, public health 
provision is the responsibility of state governments, who 
decide how to implement health initiatives. Districts (average 
population: 1.9 million) are the smallest administrative units 
of states and health programmes are implemented locally by 
district health societies.
Services for sick and preterm infants in India have been 
rapidly expanded over the last decade.27 Since 2008, the na-
tional government has established 525 district-level special 
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newborn care units, which cover 414 
districts. The remaining 208 districts 
are expected to be covered soon.28 How-
ever, the quality of neonatal care varies 
and current policies do not include the 
control of retinopathy of prematurity.29 
Treatment of the condition has mostly 
been undertaken by the not-for-profit 
eye sector – provision by the govern-
ment sector is minimal. Although there 
are no formal government guidelines for 
retinopathy of prematurity screening, 
the national government has mandated 
that preterm infants with a birth weight 
under 2000 g be screened for retinopa-
thy of prematurity no later than 30 days 
after birth.5 Babies admitted to neonatal 
units should be screened, with systems 
to ensure high coverage.".
Retinopathy of prematurity is 
included in three national, vertical 
programmes: (i) the National Child 
Health Programme recommends inten-
sive neonatal care for all preterm and 
low-birth-weight infants, as indicated 
in the 2014 Newborn Action Plan;30 
(ii) Rashtriya Bal Swasthya Karyakram 
provides screening and early interven-
tion services for children with specific 
conditions, including retinopathy of 
prematurity; and (iii) the National 
Programme for Control of Blindness is 
involved in preventing avoidable blind-
ness, including increasing the ability 
of medical schools to screen and treat 
retinopathy of prematurity.
In India, there is no systematic 
screening for the complications of diabe-
tes, such as diabetic retinopathy, despite 
a rapid increase in the incidence of the 
disease. Retinal examinations are per-
formed opportunistically when people 
with diabetes visit an eye facility, though 
often only after vision loss. Diabetic 
retinopathy is included in two national, 
vertical programmes: (i) the National 
Programme for Prevention and Control 
of Cardiovascular Diseases, Cancers, 
Diabetes and Stroke, established in 2010, 
is responsible for all noncommunicable 
diseases – programme personnel are 
responsible for the identification and 
registration of people with diabetes and 
for providing monthly medication; and 
(ii) the National Programme for Control 
of Blindness assists in the diagnosis and 
management of diabetic retinopathy.
For both diabetic retinopathy and 
retinopathy of prematurity, there is a 
lack of synergy between these verti-
cal programmes, little collaboration 
between eye-care professionals and 
professionals who manage preterm 
infants or diabetes, and limited aware-
ness among families of the implications 
of prematurity and diabetes for vision 
loss. In addition, the majority of people 
affected live in rural areas, are relatively 
poor and uneducated and cannot afford 
private health care.31 The provision of 
universal eye health, with an emphasis 
on better access for the poorest individu-
als, is crucial.32 In India, this will involve 
integrating strategies for the control of 
diabetic retinopathy and retinopathy of 
prematurity into the existing health-care 
system.
Health systems and policies play 
critical roles in determining how health 
services are delivered and used and, con-
sequently, influence health outcomes.33 
In the early 2010s in India, there was 
a need for specific policies and for 
advocacy to prevent vision loss from 
retinopathy of prematurity and diabetic 
retinopathy, both important causes of 
avoidable blindness. Although the two 
conditions present different challenges, 
because of differences in their time of 
onset and severity, in the age groups 
affected and in the urgency and level of 
care required, they can be prevented, 
detected and managed using similar 
strategies, which could be embedded 
in policies. The recent, government-
supported, expansion of the public 
health system, particularly in rural areas, 
provided an opportunity to explore ways 
of meeting these challenges.33
Pilot projects
Since 2014, the public health system in 
India has been engaged in pilot projects 
on the control of retinopathy of prema-
turity and diabetic retinopathy (Table 1). 
The projects were both supported by 
the Queen Elizabeth Diamond Jubilee 
Trust and were managed by the Public 
Health Foundation of India. The overall 
goal was to develop models of care to 
reduce avoidable blindness from the two 
conditions by integrating screening and 
treatment into the public health system 
at every level in a way that was scalable 
and sustainable. There was a need for 
transformational change and similar 
approaches were adopted for the two 
conditions (Fig. 1).
With the assistance of the national 
government, two separate national task 
forces were established. They comprised 
professional experts, public health per-
sonnel, staff responsible for national 
government programmes and staff 
from nongovernmental organizations 
and other agencies, such as the United 
Nations Children's Fund (UNICEF). 
The task forces identified key strategies 
and the processes to be implemented 
and have important coordinating and 
oversight roles. States that expressed a 
willingness to participate in the pilot 
projects and, subsequently, to extend 
activities to others areas of the state 
were prioritized, if they met feasibility 
criteria. The task forces also identified 
performance indicators, established a 
monitoring matrix for reporting and 
created a dedicated online database for 
each of the two conditions. Each task 
force set up technical expert groups to 
support decision-making and project 
implementation. The objectives and 
expected outcomes of the pilot projects 
are summarized in Box 1.
Retinopathy of prematurity
In 2013, a national summit on retinopa-
thy of prematurity identified major gaps 
in services and delegates recommended 
four main strategies to deal with them: 
(i) improve the ability of neonatal care 
units to reduce the risk of sight-threat-
ening retinopathy of prematurity; (ii) in-
tegrate the screening and treatment of 
retinopathy of prematurity into child 
health services; (iii) establish a hub-and-
spoke model (comprising three or four 
special newborn care units around one 
medical school) in each state to provide 
screening and treatment; and (iv) estab-
lish public–private partnerships, where 
applicable, so that existing expertise in 
neonatal care and eye care can be used 
to mentor staff in special newborn care 
units and eye-care professionals in the 
public health sector.
The national task force for reti-
nopathy of prematurity started work in 
2014. A situation analysis was carried 
out in nine states and state programme 
officials underwent awareness training. 
The existing national database for spe-
cial newborn care units was consulted to 
obtain data. Such as on the number of 
preterm infants admitted, and site visits 
provided additional information on 
capacity, infrastructure, equipment, fa-
cilities, personnel and staff capabilities at 
public sector special newborn care units 
and eye-care service providers in local 
district hospitals and medical schools. 
The task force identified five states where 
the retinopathy of prematurity pilot 
project could be implemented based on 
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preterm birth admission rates, survival 
rates, infrastructure, the commitment 
of the state government and the will-
ingness of neonatal and eye-care teams 
to participate. In addition, mentoring 
institutions for eye care and neonatal 
care were identified in each state. Fi-
nally, agreements were signed with four 
states and strategies approved by state 
coordination committees were imple-
mented. It was agreed that screening 
for retinopathy of prematurity would be 
embedded within special newborn care 
units and neonatal intensive care units, 
with responsibility shared between 
neonatal care and eye-care personnel. 
Rashtriya Bal Swasthya Karyakram was 
responsible for coordinating screen-
ing, referral and long-term follow-up. 
A technical expert group developed a 
comprehensive quality improvement 
package, which was being rolled out at 
the time of writing.
The retinopathy of prematurity pilot 
project aimed to promote programme 
coordination, professional collabora-
tion and partnership: (i) programme 
coordination between the National 
Child Health Programme, Rashtriya Bal 
Swasthya Karyakram and the National 
Programme for Control of Blindness; 
(ii) professional collaboration between 
ophthalmologists and neonatal care 
teams; and (iii) partnerships between 
public health services, nongovernmental 
organizations and the private sector. 
Substantial investment was also made 
in developing educational material to 
promote the best neonatal care practices 
for ensuring infant survival without 
retinopathy of prematurity. The World 
Health Organization’s (WHO’s) health 
Table 1. Diabetic retinopathy and retinopathy of prematurity pilot project initiatives at public health-care facilities, India, 2014–2018
Health-care level Health-care facility and personnel Pilot project initiative
Primary – first point of 
contact
Subcentres: 1 per 5 000 population, each with 2 
health workers and an additional female health 
worker (155 069 subcentres were operating in 2017); 
in each village, there was 1 accredited social health 
activist who acted as the community link for health 
programmes for every 1 000 people
Diabetic retinopathy: (i) annual screening for diabetes 
implemented at the community level, with people with 
a high random blood sugar level referred to medically 
qualified personnel at primary health centres. 
Diabetic retinopathy and retinopathy of prematurity: 
(i) accredited social health activists were made aware 
of the need to screen people with diabetes for diabetic 
retinopathy; and (ii) accredited social health activists and 
female health workers were made aware of retinopathy of 
prematurity
Primary – first point of 
contact with medically 
qualified personnel
Primary health centres (1 per 30 000 population) that 
provide integrated health-care services for health 
promotion, prevention and cure and each have 1–2 
medical officers supported by 15 paramedical staff 
(25 354 were operating in 2017)
Diabetic retinopathy: (i) register of people with diabetes 
established; (ii) diabetes drugs provided for free; and 
(iii) medical staff received training on diabetic retinopathy
Secondary – first 
point of contact with 
specialists
Community health centres (1 per 100 000 population) 
that provide in-patient facilities, employ 4 medical 
officers supported by 21 paramedical personnel each, 
and have internal medicine, paediatric and obstetric 
specialists and ophthalmic assistants for refraction 
and vision testing and postoperative care (5 510 were 
operating in 2017)
Diabetic retinopathy: (i) these centres were the first formal 
structures embedded in the diabetic retinopathy pilot 
projects that had the necessary infrastructure for screening 
for diabetic retinopathy; (ii) tablet computers were 
provided to register people with diabetes who attended 
these centres and were receiving treatment; (iii) 1 or 2 
medical officers at each centre received training on diabetic 
retinopathy; (iv) fundus cameras provided for diabetic 
retinopathy screening; and (v) ophthalmic assistants 
underwent training in image capture and storage, with an 
emphasis on the initial grading of images
Secondary – referral 
pathway
District health centres (1 per 1.0–1.5 million 
population) that provide advanced care in most 
medical specialties and have an ophthalmologist, 
ophthalmic assistant, paediatrician and obstetrician 
(600 were operating in 2017)
Retinopathy of prematurity: (i) these centres provided 
the points of integration for retinopathy of prematurity 
screening; (ii) quality improvements were implemented in 
neonatal teams; (iii) staff and ophthalmologists in neonatal 
care units underwent training in setting up, managing 
and undertaking screening for retinopathy of prematurity; 
(iv) 1–2 ophthalmologists at each centre underwent 
training in both retinopathy of prematurity screening 
and laser treatment; and (v) equipment was provided 
for screening (i.e. indirect ophthalmoscopes) and laser 
treatment. 
Diabetic retinopathy: (i) ophthalmologists trained to 
diagnose diabetic retinopathy and treat the condition using 
lasers and anti-vascular endothelial growth factors; and 
(ii) equipment provided for treatment
Tertiary – specialized 
referral pathway
Medical schools that are managed by the directorate 
of medical education and provide specialized medical 
care, including rehabilitation
Retinopathy of prematurity and diabetic retinopathy: 
(i) medical schools acted as mentoring partners on diabetic 
retinopathy and retinopathy of prematurity for staff in 
neighbouring districts. 
Retinopathy of prematurity: (i) ophthalmologists were 
trained to screen for the condition and provided with 
equipment, such as lasers, for treatment
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system framework was used in develop-
ing the pilot project (Table 2).34
Diabetic retinopathy
In 2013, situation analyses of the man-
agement of diabetes and diabetic reti-
nopathy was performed in the 11 most 
populous cities across nine states in 
India: it considered infrastructure, fa-
cilities, staff skills and capacity, and the 
perceptions of both people with diabetes 
and service providers.35 A critical find-
ing was that, despite being aware that 
diabetes can affect the eyes, 45.7% of 
people with diabetes who attended eye 
clinics already had vision loss.36 The 
results of the analysis were presented at 
a national summit in 2014. In response 
to the summit declaration, the national 
government constituted a national 
task force to prepare and implement a 
four-year pilot project for 2015 to 2019 
to reduce vision loss from diabetic reti-
nopathy. This task force agreed that the 
control of blood glucose, lipid levels and 
of hypertension should be addressed, 
and a technical expert group developed 
an educational package for physicians on 
managing diabetes and diabetic retinop-
athy. Members of the task force stressed 
that shared responsibility between phy-
sicians and ophthalmologists should be 
fostered and that the screening of people 
with diabetes should be embedded 
within the National Programme for Pre-
vention and Control of Cardiovascular 
Diseases, Cancers, Diabetes and Stroke 
and should take place in clinics where 
they are regularly managed. This was a 
paradigm shift.
As with the retinopathy of prematu-
rity pilot project, the diabetic retinopa-
thy pilot project aimed to promote pro-
gramme coordination, professional col-
laboration and partnership in the health 
system: (i) programme coordination 
between the National Programme for 
Control of Blindness and the National 
Programme for Prevention and Control 
of Cardiovascular Diseases, Cancers, 
Diabetes and Stroke; (ii) professional 
collaboration between ophthalmologists 
and diabetic physicians; and (iii) part-
nerships between public health services, 
nongovernmental organizations and 
the private sector. The pilot project was 
based on the assumption that the inte-
gration of diabetic retinopathy screening 
into noncommunicable disease clinics in 
districts where the National Programme 
for Prevention and Control of Cardio-
vascular Diseases, Cancers, Diabetes 
and Stroke was operating, would be 
feasible and sustainable.
Strategies for implementing the 
pilot project were agreed in consultation 
with state governments at all levels. The 
establishment of services in the public 
health system was supported by men-
tors, who were mostly nongovernmental 
organizations. Ten districts were identi-
fied for the pilot projects, based on the 
prevalence of diabetes, on involvement 
in the National Programme for Preven-
tion and Control of Cardiovascular 
Diseases, Cancers, Diabetes and Stroke, 
on the presence of mentoring institu-
tions willing to play a role in building 
capacity, mentoring and management, 
and on geographical spread. As with the 
retinopathy of prematurity pilot project, 
WHO’s health system framework was 
used during development (Table 2).
Pilot project 
implementation
During the first two years of the pilot 
projects, the focus was on establishing 
sustainable and scalable systems for 
controlling the two conditions. This was 
achieved. Both projects encountered 
challenges associated with an increased 
workload, the shortage of skilled staff, 
including trained ophthalmologists, and 
a lack of equipment. The pilot projects 
were rolled out sequentially, implemen-
tation started first in districts with better 
capacity. In many states, coming to an 
agreement with the state government 
took time. However, it was worthwhile, 
because it ensured local engagement and 
sustainability. Local elections and natu-
Fig. 1. Flow diagram, retinopathy of prematurity and diabetic retinopathy pilot 
projects, India, 2014–2018
• Conduct situational analyses and share findings with the government and other stakeholders at national summits 
on retinopathy of prematurity (2013) and diabetic retinopathy (2014)
• Disseminate findings through scientific publications and conferences.
• Regularly monitor project implementation and provide feedback to all stakeholders.
• Ministry of Health of the Government of India to establish separate national task forces for retinopathy of prematurity 
and diabetic retinopathy to oversee the identification of priority states and districts and to guide implementation of the 
pilot projects.
• Convene periodic review meetings and share feedback with national task force.
• Set up technical expert groups to support the national task forces in: (i) advocacy; (ii) communications; (iii) improving the 
quality of neonatal care in SNCUs; (iv) monitoring and evaluation; (v) capacity building of eye care teams; (vi) capacity 
building of physicians for diabetic retinopathy and of neonatologists, pediatricians, nurses and obstetricians for 
retinopathy of prematurity; (vii) devising operational guidelines; and (viii) developing technical guidelines.
• For retinopathy of prematurity, identify states with: (i) well-established, functioning, district hospital SNCUs with a large 
number of preterm admissions and adequate staffing and equipment to support high-quality neonatal care; and (ii) 
medical colleges with established neonatal care and ophthalmology units that are willing to participate in screening and 
to receive referrals from district hospitals.
• For diabetic retinopathy, identify districts where the National Program for Prevention and Control of Cardiovascular 
Diseases, Cancers, Diabetes and Stroke and the National Program for Control of Blindness have been established for 1 or 2 
years and mentoring partners exist for eye care and diabetic care.
• Identify state governments willing to support the projects and scale them up if successful.
• Sign agreements with state governments to ensure the sustainability and scaling up of the projects after the pilot phase.
• Establish state coordination committees for both retinopathy of prematurity and diabetic retinopathy and, additionally 
for diabetic retinopathy, establish district coordination committees to steer the pilot projects.
• Set up separate monitoring and oversight groups for retinopathy of prematurity and diabetic retinopathy.
• Convene regular review meetings and share feedback.
• In addition: (i) provide equipment; (ii) augment infrastructure; (iii) train staff; (iv) develop information, education and 
communication material; (iv) raise the awareness of professionals and people affected; (v) set up peer support groups; 
(vi) establish a helpline for diabetic retinopathy; and (vii) develop a web site and software to support the projects.
SNCU: sick newborn care unit.
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ral disasters delayed implementation in 
some states. The desired outcome was 
that the pilot projects should become 
integrated into the public health system 
and should over time be extended to 
other districts in participating states 
and to other non-participating states. 
This required substantial advocacy as 
it was not easy to convince some state 
governments to participate, because of 
competing health priorities. Moreover, 
some state and district coordination 
committees did not meet regularly. Part-
ner organizations responsible for project 
implementation are being supported in 
their efforts to convene these meetings 
as active government engagement is 
critical to success.
For retinopathy of prematurity, spe-
cific challenges included: (i) poor coor-
dination between neonatal care and eye-
care services; (ii) a lack of synergy and 
trust between the public sector (where 
most preterm babies are treated) and the 
not-for-profit and private sectors, which 
have the expertise; and (iii) limited 
awareness of the risk of retinopathy of 
prematurity.37 In addition, states were 
initially reluctant to send district oph-
thalmologists for 8 to 10 weeks’ training 
in retinopathy of prematurity. Training, 
supportive supervision and encourage-
ment helped overcome these problems. 
At the outset, mentoring partners found 
it difficult to persuade states to convene 
state coordination committee meetings.
For diabetic retinopathy, uptake 
of screening was poor initially due to 
a lack of awareness among people with 
diabetes of the seriousness of the disease 
and its complications and of the need 
for repeated visits to different special-
ists and for lifelong medication. Other 
challenges included: (i) poor commu-
nication between physicians treating 
people with diabetes and ophthalmolo-
gists; (ii) a reluctance to task-share; and 
(iii) the absence of structured follow-up 
mechanisms. The lack of affordable 
anti-vascular endothelial growth factors 
was also a challenge in the beginning, 
but later some state governments made 
budgetary allocations for supplies. In 
addition, implementation was hampered 
in many districts, because dedicated 
personnel and clinic space were not 
available. Another challenge was track-
ing people with diabetes through the 
care pathway, from noncommunicable 
disease clinics, through to eye-care 
providers. Project software was not 
used optimally in some states. In some 
districts, eye-care personnel, such as 
ophthalmic assistants, who could be 
trained to screen for diabetic retinopa-
thy were not available.
Sustainability
The retinopathy of prematurity pilot 
project has already led to major benefits: 
there is greater awareness of the need for 
systematic screening and screening has 
been introduced in non-participating 
districts. Moreover, some state gov-
ernments have provided equipment 
to non-participating special newborn 
care units and have adopted the same 
hub-and-spoke model for expanding 
retinopathy of prematurity services. The 
pilot project also gave nongovernmental 
organizations the confidence to offer 
support to the public health sector; two 
non-participating states, encouraged 
by increased awareness and technical 
support, have started retinopathy of pre-
maturity programmes with the help of 
nongovernmental organizations. Many 
other non-participating states have also 
requested technical support to start reti-
Box 1. Objectives and expected outcomes, retinopathy of prematurity and diabetic 
retinopathy pilot projects, India, 2014–2018
Retinopathy of prematurity pilot project
Objectives
• Advocacy for policy change at national and state government levels.
• Development of teaching modules and methods for quality improvement training for 
neonatal care teams.
• Development of national guidelines for the prevention of blindness from retinopathy of 
prematurity.
• Increased capacity of eye care and neonatal care teams in the public health sector.
• Identification, implementation and evaluation of integrated models for the screening and 
treatment of retinopathy of prematurity at 3 or 4 district hospitals and a medical school in 
each of 4 or 5 Indian states.
• Feasibility assessment of the pilot project.
• Identification of lessons learnt to help implement screening and treatment in non-
participating locations.
Expected outcomes
• By the end of 2017, government agencies should have issued at least two documents or 
orders on policy changes affecting retinopathy of prematurity.
• By the end of 2018, at least 50% of infants with a birth weight < 2000 g treated in special 
newborn care units should have been screened for retinopathy of prematurity within 30 
days of birth.
• By the end of 2018, the proportion of infants with severe retinopathy of prematurity treated 
within 48 hours of diagnosis should have increased by 25%.
Diabetic retinopathy pilot project
Objectives
• Advocacy for policy change at national and state government levels.
• Development of national guidelines for diabetic retinopathy screening and management.
• Increased capacity of eye care and physician teams.
• Improvements in the knowledge and skills of people with diabetes and their families on 
managing diabetes and its risk factors, including diabetic retinopathy.
• Identification, implementation and evaluation of integrated models of care for diabetes 
and its eye complications in 8–10 pilot districts (approximate population per district: 5 
million) in a total of 10 states.
• Feasibility assessment of the pilot project.
• Identification of lessons learnt to help implement screening and treatment in non-
participating locations.
Expected outcomes
• By the end of 2018, the proportion of people with diabetes screened for diabetic retinopathy 
should have increased by 50%.
• By the end of 2019, the proportion of people diagnosed with diabetes being screened 
annually should have increased by 50%.
• By the end of 2018, 75% of registered people with diabetes should be aware of the risk of 
visual impairment from diabetic retinopathy.
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nopathy of prematurity programmes. In 
addition, UNICEF, the agency providing 
technical support for child health at 
national and state levels, has included 
retinopathy of prematurity in their next 
five-year plan. The National Programme 
for Control of Blindness is also planning 
to provide funds for public sector medi-
cal schools to strengthen their capacity 
to screen and treat retinopathy of pre-
maturity and to expand services. Infor-
mation, education and communication 
materials developed for the project in 
local languages have been distributed 
widely to both health-care providers 
and parents. Software developed for the 
retinopathy of prematurity pilot project 
is being used for the follow-up, referral, 
coordination and monitoring of ser-
vices. Moreover, the state coordination 
committees established for the project 
are providing platforms for participants 
to share details of their concerns and 
successes and to seek the support of 
policy-makers.
Awareness of the need for system-
atic screening for diabetic retinopathy 
has increased over time. Many state 
governments have introduced service 
delivery models similar to that used in 
the diabetic retinopathy pilot project 
in non-participating districts. In ad-
dition, the pilot project also attracted 
the attention of the for-profit private 
sector. For example, in Andhra Pradesh 
State, a leading for-profit hospital chain 
entered into an agreement with the state 
government to install fundus cameras 
in all primary care facilities and to pro-
vide comprehensive eye care, including 
screening for diabetic retinopathy. In 
Odisha State, the government has ear-
marked resources to develop the skills 
and infrastructure needed for compre-
hensive eye care, including screening for 
diabetic retinopathy. Similar compre-
hensive screening programmes are being 
planned in Gujarat, Karnataka, Kerala 
and Telangana States. The National 
Programme for Control of Blindness is 
also planning to involve states not cov-
ered by the pilot project. Information, 
education and communication materials 
are available in 10 local languages and 
the tablet computers provided in the 
projects to register people with diabetes 
are being used in six states, particularly 
for arranging follow-ups. The project’s 
district coordination committees pro-
vide fora where participants can share 
details of successes and concerns with 
policy-makers and programme manag-
ers in the public health system, which 
has increased the states’ sense of respon-
sibility. Finally, implementation reviews 
are conducted regularly to help project 
partners learn from each other.
Our pilot projects for controlling 
diabetic retinopathy and retinopathy 
of prematurity have demonstrated that 
screening and treatment can be success-
fully integrated into the public health 
system using a partnership approach 
in a way that ensures sustainability and 
fosters comprehensive eye care. This ap-
proach could also be used for other po-
tentially blinding conditions. Moreover, 
there are indications that the Govern-
ment of India’s health plans are dynamic 
and respond to evidence provided by 
such projects. For example, the priorities 
of the National Programme for Control 
of Blindness have evolved and adapted 
to epidemiological trends over the past 
four decades. Initially, the emphasis was 
on trachoma and vitamin A deficiency. 
Then, based on evidence from national 
surveys, cataracts became a priority.38–42 
Recent studies have found a decline in 
the prevalence of cataract blindness and 
national plans now support a compre-
hensive approach to eye care.43–45 ■
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صخلم
دنلها ،ةماعلا ةحصلا ماظن في هبنتج نكمي يذلا ىمعلا ةرادإو صحف جامدإ
 كانه  نأ  ماك  ،يركسلا  ضرم نم دنلهاب  ًاصخش نويلم  73  نياعي
 مدع  ةلاح  في  .(ناولأا  لبق  دلُو)  ًاسرتبم  ًاعيضر  نويلم  3.5
 صربلا  نادقفل  رطخ  كانه  نوكي  ،بسانلما  تقولا  في  صحفلا
 ،نيسرتبلما ىدل ةيكبشلا للاتعاو ،يركسلا ةيكبشلا للاتعا ببسب
 ةئشان  بابسأ  يه ينتلالحا  لاك .لياوتلا  لىع ينتعومجلما  ينتاه  في
 لىوتي ةماعلا ةحصلل جمانرب دجوي لا هنأ لاإ ،دنلها في صربلا فعضل
 2014  ماع  في  ةدئار  تاعوشرم  ينشدت  مت  .ةرادلإا  وأ  صحفلا
 ةماعلا ةحصلا مظن في تلاالحا هذه ةرادإو صحف يتيلمع جمدل
 ةصالخا ةلاحلإا تاكبشو ةيفيرلا تاعمتجلما في ةصاخو ،ةمئاقلا
 ،ةيلماعلا ةحصلا ةمظنلم عباتلا ةيحصلا مظنلا راطإ مدختسا مت .ابه
 ،ةينعلما تاهلجا لك عم تايجيتاترسا عضو مت ماك ،عيراشلما ريوطتل
 ةيرومح  جذمان  لىع  ينعوشرلما  لاك  لمتشا  .ةموكلحا  كلذ  في  ماب
 يكبشلا للاتعلال ةبسنلاب .بطلا تايلك ءاحنأ في ةياعرلا تادحول
 ماك ،ةيلولأا ةيحصلا ةياعرلا قفارم في صحفلا ءارجإ مت ،يركسلا
 للاتعلال ةبسنلاب امأ .تاعطاقلما تايفشتسم في جلاعلا ميدقت مت
 تادحو في صحفلا جمد مت دقف ،نيسرتبلما ديلاولما ىدل يكبشلا
 ينستح مت ماك ،ةعطاقلما ىوتسم لىع ضىرلما ةدلاولا يثيدح ةياعر
 في .ماعلا عاطقلا نم ةلوملما بطلا تايلك برقأ في جلاعلا قفارم
 صحفلاو يعولا في ةيربك تانيستح كانه تناك ،ينلولأا ينماعلا
 تايريغت  لىإ  ةفاضلإاب  ،ةينعلما  تاهلجا  ينب  ةكاشرلاو  جلاعلاو
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Intégration du dépistage et de la prise en charge de la cécité évitable dans le système de santé publique en Inde
En Inde, 73 millions de personnes sont atteintes de diabète et 
3,5 millions de nourrissons naissent avant terme. Lorsque le dépistage 
n'est pas effectué à temps, il existe un risque de perte de la vue due à la 
rétinopathie diabétique dans le cas du premier groupe et à la rétinopathie 
du prématuré dans le cas du second. Bien que ces deux maladies soient 
de nouvelles causes de déficience visuelle en Inde, aucun programme de 
santé publique ne vise leur dépistage ou leur prise en charge. Des projets 
pilotes ont été lancés en 2014 pour intégrer le dépistage et la prise en 
charge de ces maladies dans les systèmes de santé publique existants, en 
particulier dans les communautés rurales et leurs réseaux d'orientation. 
Le cadre des systèmes de santé de l'Organisation mondiale de la Santé a 
été utilisé pour développer ces projets et des stratégies ont été élaborées 
avec toutes les parties prenantes, et notamment le gouvernement. Les 
deux projets impliquaient des réseaux en étoile d'unités de soins autour 
des écoles de médecine. Dans le cas de la rétinopathie diabétique, 
le dépistage a été assuré dans des établissements de soins de santé 
primaires, tandis que le traitement a été appliqué dans des hôpitaux de 
district. Dans le cas de la rétinopathie du prématuré, le dépistage a été 
intégré dans des unités de soins pour les pathologies néo-natales au 
niveau des districts et les installations de traitement ont été améliorées 
dans les écoles de médecine financées par l'État les plus proches. Au 
cours des deux premières années, des améliorations considérables ont 
été constatées en matière de sensibilisation, de dépistage, de traitement 
et de partenariat entre les parties prenantes, et des changements ont été 
apportés à la politique de santé publique. En mars 2018, le dépistage de 
la rétinopathie diabétique était assuré dans 50 établissements répartis 
dans 10 États et le traitement avait été amélioré dans 10 hôpitaux, tandis 
que le dépistage de la rétinopathie du prématuré était assuré dans 
16 unités de soins pour les pathologies néo-natales dans les hôpitaux 
de district de quatre États et le traitement avait été amélioré dans six 
écoles de médecine. Un soutien au sein des administrations des États 
fédérés a été essentiel au succès de l'initiative.
Резюме
Интеграция системы общественного здравоохранения с целью скрининга и лечения предотвратимой 
слепоты, Индия
В Индии 73 миллиона человек страдают диабетом и 3,5 миллиона 
младенцев рождаются преждевременно. Без своевременного 
скрининга в этих двух группах существует риск потери зрения 
вследствие диабетической ретинопатии и ретинопатии 
недоношенных. Оба эти состояния являются растущими 
причинами нарушения зрения в Индии, но в этой стране 
нет никакой соответствующей программы общественного 
здравоохранения для скрининга или лечения. В 2014 году были 
начаты экспериментальные проекты по интеграции скрининга и 
лечения этих состояний в существующие системы общественного 
здравоохранения, особенно в сельских общинах и сети 
медицинских учреждений, находящихся в сельской местности. 
Для разработки проектов за основу была взята структура системы 
здравоохранения, рекомендованная Всемирной организацией 
здравоохранения, и стратегии были разработаны совместно со 
всеми заинтересованными сторонами, включая правительство. 
Оба проекта включали в себя модель системы здравоохранения, 
представляющую собой разветвленную сеть медицинских 
учреждений, расположенных на базе медицинских учебных 
заведений. Скрининг по поводу диабетической ретинопатии был 
внедрен в учреждениях первичной медико-санитарной помощи, 
а лечение проводилось в районных больницах. Скрининг 
по поводу ретинопатии недоношенных был интегрирован в 
неонатологические отделения больниц на районном уровне, 
а также были усовершенствованы лечебные учреждения в 
ближайших государственных медицинских учебных заведениях. 
В течение первых двух лет произошли существенные улучшения 
в информировании, скрининге, лечении и партнерстве между 
заинтересованными сторонами, а также изменения в политике 
общественного здравоохранения. К марту 2018 года скрининг по 
 حبصأ  ،2018  راذآ/سرام  لولحبو  .ةماعلا  ةحصلا  ةسايس  في
 في  ًاقفرم  50  في  ًارفاوتم  يركسلا  ةيكبشلا  للاتعا  نع  فشكلا
 حبصأ مانيب ،تايفشتسم 10 في جلاعلا ينستح مت ماك ،تايلاو 10
 ةياعرل ةدحو 16 في ًارفوتم نيسرتبلما ىدل ةيكبشلا للاتعا صحف
 متو ،تايلاو عبرأ في ةعطاقلما ىفشتسم في ضىرلما ةدلاولا يثيدح
 لخاد معدلا دوهج تناك .بطلا تايلك نم تس في جلاعلا ينستح
.ةردابلما حاجنل ةيروضر تايلاولا تاموكح
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поводу диабетической ретинопатии был внедрен на 50 объектах 
в 10 штатах, лечение было усовершенствовано в 10 больницах, 
тогда как скрининг в связи с ретинопатией недоношенных был 
внедрен в 16 неонатологических отделениях районных больниц 
в четырех штатах, а лечение было усовершенствовано в шести 
медицинских учебных заведениях. Поддержка правительств 
штатов имела решающее значение для успеха инициативы.
Resumen
Integración en el sistema de salud pública de la detección y gestión de la ceguera evitable, la India
En la India, 73 millones de personas son diabéticas y 3,5 millones 
de niños nacen prematuros. Sin exámenes de detección oportunos, 
existe un riesgo de pérdida de la visión por la retinopatía diabética y 
la retinopatía por prematuridad en estos dos grupos, respectivamente. 
Ambas afecciones son causas emergentes de discapacidad visual en la 
India, pero no existe un programa de salud pública para la detección 
o el tratamiento. En 2014 se iniciaron proyectos piloto para integrar 
el análisis y la gestión de estas condiciones en los sistemas de salud 
pública existentes, en particular en las comunidades rurales y sus 
redes de derivación. Se utilizó el marco de sistemas de salud de la 
Organización Mundial de la Salud para desarrollar los proyectos y se 
desarrollaron estrategias con todas las partes interesadas, incluido el 
gobierno. En ambos proyectos se utilizaron modelos de unidades de 
atención centralizados en torno a las facultades de medicina. En cuanto 
a la retinopatía diabética, se establecieron exámenes de detección en los 
centros de atención primaria y se ofreció tratamiento en los hospitales 
de distrito. En cuanto a la retinopatía por prematuridad, los exámenes de 
detección se integraron en las unidades de atención neonatal a nivel de 
distrito y se mejoraron las instalaciones de tratamiento en las facultades 
de medicina más cercanas financiadas con fondos públicos. En los dos 
primeros años se produjeron mejoras sustanciales en la sensibilización, 
la detección, el tratamiento y la asociación entre las partes interesadas, 
así como cambios en la política de salud pública. Para marzo de 2018, 
se establecieron exámenes de detección de retinopatía diabética en 
50 establecimientos de 10 estados y se mejoró el tratamiento en 10 
hospitales, mientras que se establecieron exámenes de detección de 
retinopatía por prematuridad en 16 unidades de atención neonatal en 
hospitales de distrito de cuatro estados y se mejoró el tratamiento en 
seis facultades de medicina. La promoción dentro de los gobiernos 
estatales fue fundamental para el éxito de la iniciativa.
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